Polski
A Recalled Drug and Climate Risk: A Week That Reminded Pharma of Its Weak Spots
This week in the pharmaceutical industry showed two sides of the same coin: how quickly you need to react when quality control fails, and how far ahead you need to think to avoid a crisis in the first place. From an urgent recall of a liver medication to alarming data on climate threats to supply chains — here's what you need to know this week.
01 · Drug Safety
GIF's Lightning-Fast Response to a Contaminated Drug
On September 23, 2026, the Chief Pharmaceutical Inspector (GIF) ordered the immediate recall of three batches of Ornispar, a drug used to treat hepatic encephalopathy [1]. The trigger was a signal from the National Medicines Institute, which detected an unidentified contaminant in one of the samples during testing. The key word here is "unidentified" — since the substance detected could not be conclusively identified, GIF could not rule out a risk to patients' health. As a result, the recall decision was made immediately enforceable, meaning the product had to disappear from pharmacies and wholesalers without delay, even before the root cause of the problem was fully established.
This case is a good illustration of how Poland's drug quality oversight system works in practice. A single signal from a control laboratory is enough to trigger a procedure that removes a potentially dangerous product from the market within days — not weeks or months. For manufacturers, it's a reminder that even a single faulty sample from one batch can trigger immediate consequences for the entire lot, while for pharmacists and patients, it's a signal to keep a close eye on GIF's official communications.
02 · Supply Chain
Climate Risk Moves Into the Boardrooms of Pharma Giants
If the story above is about managing "here and now" risk, a BSI report published on September 11, 2026 shows risk from a strategic perspective instead [2]. The study, which surveyed more than 7,000 business leaders across the G7 countries, found that as many as 87% of pharmaceutical companies expect climate-related supply chain disruptions to intensify. Interestingly, cost pressures aren't weakening environmental commitments — 96% of the companies surveyed say they will maintain their net-zero pledges despite a tougher economic environment.
These figures point to a clear shift in the narrative. Climate neutrality is no longer treated solely as an image-building exercise or a line item in an ESG report destined for the shelf — it's increasingly becoming part of a hard-nosed analysis of business resilience. In an industry whose supply chain covers pharmaceutical raw materials, packaging, and cold-chain logistics that are sensitive to weather conditions, any climate shock can mean production downtime or interruptions in drug supply. Companies that invest in the resilience of their supply chains today stand to gain a significant edge once disruptions — as most respondents predict — become more frequent.
Summary
Summary
This week shows that the pharmaceutical industry must be able to put out fires quickly — as with the Ornispar recall [1] — while also building long-term resilience against threats that are still on the horizon, such as the growing climate risk to supply chains [2]. Both of these threads — quality and predictability — are set to be among the top topics of conversation on the sidelines of industry events.
If these are topics you care about, join us at Międzynarodowe Targi Farmacji – Pharmacy Expo 2027, where experts in regulation, quality, and sustainability will discuss the challenges facing the sector. It's a chance to talk both about quality control systems and about strategies for building resilient supply chains.
Invitation
Topics like drug quality and the climate resilience of supply chains will take center stage at Międzynarodowe Targi Farmacji – Pharmacy Expo 2027. Meet experts in regulation, quality control, and sustainability who tackle these challenges every day. Join the conversation about how the industry can act faster and smarter — both in a crisis and when planning years ahead.
Pharmacy Expo 2027